Hippocampal injections of soluble amyloid-beta oligomers alter electroencephalographic activity during wake and slow-wave sleep in rats
Alzheimer’s Research and Therapy (2023) 15 (1), 174 DOI: 10.1186/s13195-023-01316-4
Proteome integral solubility alteration high-throughput proteomics assay identifies Collectin-12 as a non-apoptotic microglial caspase-3 substrate
Cell Death & Disease (2023) 14 (3), 192 DOI: 10.1038/s41419-023-05714-2
Single-domain antibody–based noninvasive in vivo imaging of α-synuclein or tau pathology
Science Advances (2023) 9 (19), eadf3775 DOI: 10.1126/sciadv.adf3775
Pharmacologic inhibition of NLRP3 reduces the levels of α-synuclein and protects dopaminergic neurons in a model of Parkinson's disease
Journal of Neuroinflammation (2023) 20 (1), 147 DOI: 10.1186/s12974-023-02830-w
Evolving prion-like tau conformers differentially alter postsynaptic proteins in neurons inoculated with distinct isolates of Alzheimer’s disease tau
Cell & Bioscience (2023) 13 (1), 174 DOI: 10.1186/s13578-023-01133-0
Endolysosomal impairment by binding of amyloid beta or MAPT/Tau to V-ATPase and rescue via the HYAL-CD44 axis in Alzheimer disease
Autophagy (2023) 19 (8), 2318-2337 DOI: 10.1080/15548627.2023.2181614
Brain-derived tau: a novel blood-based biomarker for Alzheimer's disease-type neurodegeneration
Brain (2023) 146 (3), 1152-1165 DOI: 10.1093/brain/awac407
A Hairpin Motif in the Amyloid-β Peptide Is Important for Formation of Disease-Related Oligomers
Journal of the American Chemical Society (2023) 145 (33), 18340-18354 DOI: 10.1021/jacs.3c03980
Border-associated macrophages promote cerebral amyloid angiopathy and cognitive impairment through vascular oxidative stress
Molecular Neurodegeneration (2023) 18 (1), 73 DOI: 10.1186/s13024-023-00660-1
Mutations in α-synuclein, TDP-43 and tau prolong protein half-life through diminished degradation by lysosomal proteases
Molecular Degeneration(2023) 18 (1), 29 DOI: 10.1186/s13024-023-00621-8